Sitra

Since 2007 Amsterdam-based SET Ventures has invested in digital technology for a carbon-free energy system by backing pioneering founders with capital, community, and insights. SET Ventures invests in companies with sustainable solutions and a strong digital DNA leading the systemic change of how energy is generated, distributed, stored, and consumed in sectors such as distributed infrastructure, energy retail, buildings, mobility, and industry as well as enabling technologies.

We help organizations succeed in a rapidly changing future by helping them find answers in large amounts of data that they can't otherwise see. Our algorithms help customers see the big picture in scattered data by revealing unknown connections and even explaining why they exist. 100% own IP, combines the strengths of Natural Language Processing, self-organized learning, reinforcement learning and 20+ years experience on cognitive sciences.

Naava reconnects humanity with nature. Future technology embracing millions of years of natural innovation and design lies behind the smartest green walls on the planet. At Naava, we want to help people feel better, healthier and more productive. The environment where we live, learn, and work is important for us. After all, we spend well over 90% of our time in indoors, breathing synthetic, man-made air a thousand times every hour. By 2025 a billion people can choose to breathe Nordic forest air. Everywhere. Naava brings nature inside, everywhere. We allow people to experience nature in the midst of the urban environment. Our brand promise can be explained in one word: breathe.

Optomeditech Oy was founded in June 2011, to develop and market products in the area of Intravenous Catheters and Blood Collection Needles. Currently the company is working on securing the CE mark and FDA 510(k) approval for its first IV catheter product and is planning on entering the market during the first half of 2015.

NaturVention Enclosed Ecosystem Technologies solves global problems by combining nature and technology. We are a fast growing, venture-backed technology company. We challenge ourselves to find solutions to global problems by looking into nature, from where we have been able to find solutions for thousands of years already. We have developed patented solutions by enhancing nature’s own processes. We use the brightest technology to enhance those processes in order to create products that are easy to use and which help people to feel better by providing clean and healthy air and food.

Omegawave specializes in the development of training and performance management solutions, providing athletes, teams and coaches a faster way to maximize results while avoiding injuries and overtraining. With our products, athletes can quickly, non-stressfully and non-invasively assess how their body is responding to previous exertion while gaining insights to optimize their next training session. Routine Omegawave assessments can be fluidly integrated into any training process to provide coaches with real-time data and crucial physiological information about their athletes. Omegawave products are currently used by multiple Olympic Federations, premier soccer teams, franchises from the NFL, MLS, NHL, and MLB as well as by numerous other sports organizations and individual athletes. After devoting fifteen years to the support of so many world-class competitors, in April 2014 Omegawave was recognized by the UK-based Sports Technology Awards as the developer of the ‘Best Performance Technology for Elite Athletes.’

Vision+ is a Finnish company that invests into digital products such as applications, games and services in all digital platforms. The company also invests in Internet and SaaS services, apps and sometimes in special content IP deals. The Fund’s management team has extensive background in technology, as business angels in seed investments, entrepreneurship and the creation of successful new product, content, services and business. Members of the management team have also run development and business organizations of significant scale in global setting.

Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder. The company was founded in 2000 and is headquartered in Helsinki, Southern Finland.

Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder. The company was founded in 2000 and is headquartered in Helsinki, Southern Finland.

FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.